Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2016

View Archived Issues

Avalanche Biotechnologies to acquire Annapurna Therapeutics

Starpharma reports additional preclinical results for targeted dendrimer conjugate

FDA grants fast track designation to NDI-010976 for NASH

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Mersana and Takeda expand partnership to advance development of Fleximer-based ADC therapies

Bayer Schering Pharma patents GLUT-1 inhibitors

Roche discloses BACE1 inhibitors

Merck & Co. develops ROMK channel blockers

Shionogi reports ITK inhibitors

FDA grants fast track designation for emricasan as treatment of patients with NASH cirrhosis

Shareholders approve Pozen merger with Tribute Pharmaceuticals

New AAV variant transfers genes throughout the CNS in vivo

Modulate Therapeutics established to develop immunomodulator combination IMM-01

Greenville Health System and Selah Genomics launch test for risk of sudden cardiac death

Heat Biologics provides update on its HS-410 phase II bladder cancer trial

Takeda Pharmaceutical to create wholly owned consumer healthcare subsidiary

Human fallopian tube organoid model faithfully recapitulates the mucosal fold architecture

Kyorin returns Japanese rights to aclidinium/formoterol to AstraZeneca

Defibrotide deemed effective against veno-oclussive disease in phase III trial

Pfizer profiles pipeline progress of fourth quarter 2015

Exosome-encapsulated paclitaxel shows promise to treat drug-resistant cancers

FDA grants fast track designation to TapImmune's TPIV-200 for ovarian cancer

FDA advisory committee votes on Brintellix to treat cognitive dysfunction in MDD

Mitsubishi Tanabe Pharma updates progress of third quarter of fiscal 2015

Morphotek provides folate receptor alpha diagnostic assays for Mayo Clinic study

GeoVax Labs announces its plans to develop Zika virus vaccine

Fast Forward Pharmaceuticals begins phase II studies of FFP-104

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...